Literature DB >> 19488078

Are some antidepressants better than others?

Gerald Gartlehner, Richard A Hansen.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19488078     DOI: 10.1038/nrneurol.2009.51

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes.

Authors:  Jonathan J Deeks
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Antidepressants are not all created equal.

Authors:  Sagar V Parikh
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

3.  Odds ratios should be avoided when events are common.

Authors:  D G Altman; J J Deeks; D L Sackett
Journal:  BMJ       Date:  1998-11-07

4.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

5.  Indirect comparisons of competing interventions.

Authors:  A M Glenny; D G Altman; F Song; C Sakarovitch; J J Deeks; R D'Amico; M Bradburn; A J Eastwood
Journal:  Health Technol Assess       Date:  2005-07       Impact factor: 4.014

Review 6.  The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

Authors:  R Michael Bagby; Andrew G Ryder; Deborah R Schuller; Margarita B Marshall
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

Review 7.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

Review 8.  Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Authors:  Gerald Gartlehner; Bradley N Gaynes; Richard A Hansen; Patricia Thieda; Angela DeVeaugh-Geiss; Erin E Krebs; Charity G Moore; Laura Morgan; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2008-11-18       Impact factor: 25.391

9.  Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Thomas D Denberg; Mary Ann Forciea; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-11-18       Impact factor: 25.391

  9 in total
  1 in total

Review 1.  The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.

Authors:  Gerald Gartlehner; Kylie Thaler; Richard A Hansen; Bradley N Gaynes
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.